Browsing by Author "Correia, S."
Now showing 1 - 4 of 4
Results Per Page
Sort Options
- O Biólogo Especialista em SaúdePublication . Sousa, A.; Marques, B.; Júlio, C.; Guia Pereira, A.; Correia, H.; Ávila, M.; Rendeiro, P.; Monteiro, M.; Lopo, S.; Pinheiro, J.; Cunha, N.; Figueiredo, H.; Correia, S.; Ramos, S.A presença do Biólogo com atividade na saúde teve nas últimas décadas notável incremento, em hospitais, institutos e centros de saúde, universidades, laboratórios privados e indústria, em particular nas áreas de investigação, análises clínicas, genética humana, embriologia/reprodução humana, entre outras. Persistem, todavia, alguns constrangimentos para estes profissionais de saúde, no acesso à profissão e na consequente atribuição de responsabilidades técnicas e científicas. Cabe à OBIO a defesa, regulação e certificação dos seus profissionais, bem como garantir códigos de conduta e formação contínua determinantes para a elevada qualidade que se espera destes. De igual modo, o CBHS assume as competências estatutárias na definição dos seus objetivos de forma a garantir o bom exercício da atividade profissional dos seus membros, e o reconhecimento destes pela Sociedade e Instituições.
- Characterization of pediatric patients from Portuguese FH studyPublication . Abrantes, LB.; Alves, A.C.; Medeiros, A.M.; Correia, S.; Cruz, A.; Lobarinhas, G.; Garcia, P.; Guerra, A.; Mansilha, H.; Martins, E.; Martins, P.; Salgado, J.; Bourbon, M.; on behalf of investigators of Portuguese FH studyThe Portuguese FH Study (PFHS) started in 1999. The aim of the PFHS is to identify the cause of dyslipidemia in patients with a clinical diagnosis of FH. To date, 452 pediatric patients were referred to us, 288 of which are index patients. The aim of this study was to analyse the lipid profile and molecular diagnosis of children recruited for the PFHS.
- A familial partial AZFb-c microdeletion associated with diferente fértile phenotypesPublication . Pereira, I.; Aguiar, A.; Correia, S.; Pinto, M.G.; Calhaz Jorge, C.; Gonçalves, J.After the Klinefelter syndrome, Y chromosome microdeletions are the second most frequent genetic cause of spermatogenic failure resulting in male infertility. Y chromosome microdeletions, encompassing one or more of the three AZF regions, are associated with diverse testicular histology, ranging from Sertoli-cell-only syndrome (AZFa del), maturation arrest (AZFb del) to hypospermatogenesis (AZFc del). The molecular screening of these regions is routinely performed in the work-up of infertile patients with azoospermia or severe oligozoospermia as each one has different prognostic values, both in terms of clinical decision-making and appropriate genetic counselling as well as for understanding the etiology of spermatogenesis impairment. Different partial AZFc deletions were already described, although it is still controversial if these are truly a genetic risk factor for spermatogenesis impairment or a deletional variant without phenotypic consequences. Here we present the molecular results obtained after AZF analysis of two infertile brothers (both diagnosed with oligoteratoastenozoospermia), and of their fertile father. Several multiplex-PCR assays were performed with distinct sets of STS markers, specific for the three AZF regions. The molecular analysis revealed that all three men presented the same partial AZFb/c microdeletion, namely the absence of the sY1197, sY1291 and sY1192 STSs. This microdeletion probably results from the recombination of amplicons b1/b3, reducing the gene copy number of PRY, BPY, DAZ, and RBMY. The b1/b3 deletion is rare and its influence on spermatogenesis is still not clear since it can be found in men with severe oligozoospermia or with normal sperm counts. Our result suggests that b1/b3 del is most likely a risk factor predisposing to spermatogenic failure, but is not sufficient alone. The different (in)fertile phenotypes associated with it, a fertile father opposed to his two infertile sons, can be possibly influenced by genetic background, environmental and epigenetic factors, contributing to different phenotypic expressions of individual/specific genomes.
- Pediatric Familial HypercholesterolaemiaPublication . Abrantes, L.B.; Alves, A.C.; Medeiros, A.M.; Correia, S.; Cruz, A.; Ferreira, A.C.; Lobarinhas, G.; Garcia, P.; Guerra, A.; Mansilha, H.; Martins, E.; Martins, P.; Salgado, J.M.; Bourbon, M.; on behalf of investigators of Portuguese FH StudFamilial hypercholesterolemia (FH) is an autosomal dominant disorder associated with high levels of LDL-c and premature CHD (pCHD). Identification of FH in pediatric age is essential for a timely diagnosis and management. This study aims to highlight the importance of FH diagnosis in children.